BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17768125)

  • 1. Down-regulation of WT1/+17AA gene expression using RNAi and modulating leukemia cell chemotherapy resistance.
    Shen H; Xu W; Wu Z; Tang H; Xie Y; Zhong X
    Haematologica; 2007 Sep; 92(9):1270-2. PubMed ID: 17768125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line.
    Zhang YY; Xie KM; Yang GQ; Mu HJ; Yin Y; Zhang B; Xie P
    Int J Hematol; 2011 Mar; 93(3):361-367. PubMed ID: 21380926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
    Han F; Liu G; Sun C; Wei J
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
    Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of WT1 gene down regulation on the sensitivity of K562/A02 cells to adriamycin].
    Yang T; Wang HW; Xu J; Zhang L; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):373-6. PubMed ID: 19951528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal effect of bufalin on multidrug resistance in K562/VCR vincristine-resistant leukemia cell line.
    Zhai X; Lu J; Wang Y; Fang F; Li B; Gu W
    J Tradit Chin Med; 2014 Dec; 34(6):678-83. PubMed ID: 25618972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
    Zhu CY; Lv YP; Yan DF; Gao FL
    Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp.
    Zhang X; Xiao W; Wang L; Tian Z; Zhang J
    PLoS One; 2011; 6(6):e20965. PubMed ID: 21677772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirarubicin nuclear uptake does not correlate with its induced cell death effect during reversal of multidrug resistance by quinine in human K562 and CEM leukemic cells.
    Morjani H; Belhoussine R; Lahlil R; Manfait M
    Eur J Haematol; 1998 Oct; 61(4):240-9. PubMed ID: 9820630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-138 might reverse multidrug resistance of leukemia cells.
    Zhao X; Yang L; Hu J; Ruan J
    Leuk Res; 2010 Aug; 34(8):1078-82. PubMed ID: 19896708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca
    Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K
    J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine reverses the drug resistance of leukemic K562/ADM cells by inhibiting autophagy.
    Wang F; Zhang Z; Leung WT; Chen J; Yi J; Ying C; Yuan M; Wang M; Zhang N; Qiu X; Wang L; Wei H
    Mol Med Rep; 2019 Oct; 20(4):3883-3892. PubMed ID: 31485616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].
    Xiao XB; Xie ZX; Qin Q
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
    Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
    Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.